Insight

Nico Gagelmann: Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older

Photo of Nico Gagelmann from vjhemonc.com

Aug 5, 2024, 14:06

Nico Gagelmann: Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older

Nico Gagelmann, shared a post on X:

“Finally out!

Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older: A study from the German Registry for Stem Cell Transplantation.”

Nico Gagelmann

Source: Nico Gagelmann/X

Authors: Nico Gagelmann, Claudia Schuh, Robert Zeiser, Matthias Stelljes, Wolfgang Bethge, Gerald Wulf, Daniel Teschner, Stefan Klein, Eva Wagner-Drouet, Edgar Jost, Peter Dreger, Sarah Flossdorf, and Nicolaus Kröger.

Nico Gagelmann

Allogeneic Hematopoietic Cell Transplantation cancer Claudia Schuh Daniel Teschner Edgar Jost Eva Wagner-Drouet Gerald Wulf Matthias Stelljes myelofibrosis Nico Gagelmann Nicolaus Kröger OncoDaily Oncology Peter Dreger Robert Zeiser Sarah Flossdorf Stefan Klein Wolfgang Bethge

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology